Astellas Pharma Inc. (ALPMY)

USD 9.53

(-0.14%)

Eps Summary of Astellas Pharma Inc.

Astellas Pharma Inc.'s latest annual eps in 2024 was 9.47 JPY , down -82.54% from previous year.
Astellas Pharma Inc.'s latest quarterly eps in 2024 FY was N/A , down -82.49% from previous quarter.
Astellas Pharma Inc. reported an annual eps of 54.24 JPY in 2023, down -19.14% from previous year.
Astellas Pharma Inc. reported an annual eps of 67.08 JPY in 2022, up 3.31% from previous year.
Astellas Pharma Inc. reported a quarterly eps of 18.46 JPY for 2024 Q1, up 172.42% from previous quarter.
Astellas Pharma Inc. reported a quarterly eps of N/A for 2024 FY, down -82.49% from previous quarter.

Annual Eps Chart of Astellas Pharma Inc. (2024 - 2013)

Historical Annual Eps of Astellas Pharma Inc. (2024 - 2013)

Year	Eps	Eps Growth
2024	9.47 JPY	-82.54%
2023	54.24 JPY	-19.14%
2022	67.08 JPY	3.31%
2021	64.93 JPY	-37.66%
2020	104.15 JPY	-9.47%
2019	115.05 JPY	41.84%
2018	81.11 JPY	-21.78%
2017	103.69 JPY	15.53%
2016	89.75 JPY	46.17%
2015	61.40 JPY	52.02%
2014	40.39 JPY	12.1%
2013	36.03 JPY	0.0%

Year	Eps	Eps Growth
2024 Q4	-18.56 JPY	-329.42%
2024 Q1	18.46 JPY	172.42%
2024 FY	- JPY	-82.49%
2024 Q2	-0.81 JPY	-104.39%
2024 Q3	8.09 JPY	1098.77%
2023 FY	- JPY	-19.14%
2023 Q4	-25.49 JPY	-195.97%
2023 Q3	26.56 JPY	-32.42%
2023 Q2	39.30 JPY	188.97%
2023 Q1	13.60 JPY	397.59%
2022 Q4	-4.57 JPY	-113.91%
2022 FY	- JPY	3.31%
2022 Q3	32.86 JPY	48.76%
2022 Q2	22.09 JPY	33.39%
2022 Q1	16.56 JPY	349.4%
2021 Q4	-6.64 JPY	-120.54%
2021 Q2	12.07 JPY	-55.49%
2021 Q1	27.12 JPY	835.17%
2021 FY	- JPY	-37.66%
2021 Q3	32.33 JPY	167.85%
2020 Q3	32.78 JPY	-11.64%
2020 Q1	31.00 JPY	91.95%
2020 FY	- JPY	-9.47%
2020 Q2	37.10 JPY	19.68%
2020 Q4	2.90 JPY	-91.15%
2019 Q4	16.15 JPY	-64.58%
2019 Q2	25.47 JPY	-7.88%
2019 FY	- JPY	41.84%
2019 Q1	27.65 JPY	150.23%
2019 Q3	45.60 JPY	79.03%
2018 Q4	11.05 JPY	-63.13%
2018 Q3	29.97 JPY	54.72%
2018 Q2	19.37 JPY	-5.7%
2018 Q1	20.54 JPY	7.2%
2018 FY	- JPY	-21.78%
2017 Q3	30.20 JPY	32.63%
2017 Q4	19.16 JPY	-36.56%
2017 FY	- JPY	15.53%
2017 Q1	31.31 JPY	129.21%
2017 Q2	22.77 JPY	-27.28%
2016 Q1	20.35 JPY	112.42%
2016 FY	- JPY	46.17%
2016 Q4	13.66 JPY	-52.29%
2016 Q3	28.63 JPY	6.35%
2016 Q2	26.92 JPY	32.29%
2015 FY	- JPY	52.02%
2015 Q2	15.43 JPY	-4.34%
2015 Q4	9.58 JPY	-52.67%
2015 Q3	20.24 JPY	31.17%
2015 Q1	16.13 JPY	283.14%
2014 Q2	11.54 JPY	17.88%
2014 Q3	14.81 JPY	28.34%
2014 FY	- JPY	12.1%
2014 Q4	4.21 JPY	-71.57%
2014 Q1	9.79 JPY	1339.24%
2013 Q4	-0.79 JPY	-106.67%
2013 Q3	11.85 JPY	25.0%
2013 FY	- JPY	0.0%
2013 Q2	9.48 JPY	0.0%

Peer Eps Comparison of Astellas Pharma Inc.

Name	Eps	Eps Difference
AstraZeneca PLC	3.84 USD	-146.615%
Bristol-Myers Squibb Company PFD CONV 2	3.88 USD	-144.072%
CSPC Pharmaceutical Group Limited	0.07 USD	-13428.571%
Clarus Therapeutics Holdings, Inc.	-8.04 USD	217.786%
Novartis AG	7.63 USD	-24.115%
PT Kalbe Farma Tbk.	0.00 USD	-242720.513%